Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial-Reference-Cited by-同舟云学术

Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial

Published:2003-01-15 Issue:2 Volume:95 Page:113-125
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Trimbos J. B.,Vergote I.,Bolis G.,Vermorken J. B.,Mangioni C.,Madronal C.,Franchi M.,Tateo S.,Zanetta G.,Scarfone G.,Giurgea L.,Timmers P.,Coens C.,Pecorelli S.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference18 articles.

1. Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer

2. Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P)

3. Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument

4. Staging Laparotomy in Early Ovarian Cancer

5. Staging laparotomy in early epithelial ovarian carcinoma

Cited by 564 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of Gynaecological Cancer: Ovarian, Endometrial and Cervical;International Encyclopedia of Public Health;2025

2. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

3. Stage IC grade 1 endometrioid adenocarcinoma of the ovary: assessment of post-operative chemotherapy de-escalation;International Journal of Gynecologic Cancer;2024-08-19

4. Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status;Gynecologic Oncology;2024-08

5. Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers;Gynecologic Oncology;2024-08